Graves’ Disease Market Trends 2018 | Segmentation, Outlook, Industry Report to 2023

The global graves disease market was estimated to USD 655 million in 2018 and expected to grow at a significant CAGR of 4.6% during the forecast period (2018-2023). Graves’ disease is an immune system disorder which results in hyperthyroidism. It is the problem that causes the thyroid gland to overproduce thyroid hormones. There are various types of treatments available in the market for diagnosis of this disease such as anti-thyroid medication, Radioactive iodine therapy, and surgeries. The global Graves disease market has been growing significantly due to various factors consist of increasing prevalence of thyroid disorder which is the reason for higher pool of patient suffering from Graves’ disease. Technological advancement in the field of Graves’ disease market has led to the innovations and introduction of various treatments such as radioactive iodine, and thionamides which helps for the emerging growth of the segment. Availability of generic drugs and favourable reimbursement policies also drive the growth of the market.

Request a Free Sample of our Graves’ Disease Market:  https://www.omrglobal.com/request-sample/graves-disease-market

Increasing awareness across the globe, deteriorating lifestyle due to consumption of alcohol and smoking, and rising thyroid tumors creates the future opportunity and will further boost the market growth. However, there are various factors acting as the barriers for this market which includes cost associated with the treatment and lack of professionals available in the rural areas.
Global Graves’ disease market can be segmented on the basis of diagnosis and treatment. Based on the diagnosis, the market can be bifurcated as ultrasound, imaging test, Radioactive Iodine Uptake and blood sample. On the basis of treatment, the market is diversified as anti-thyroid medication, radioactive iodine therapy and surgery. Among treatment, anti-thyroid medication is expected to hold the largest share due to its property of being the least non-invasive treatment.

Taking into consideration the geographical region the market has been divided into North America, Europe, Asia Pacific and rest of the world. North America dominates the market with its capability of advanced technology which provides various treatments options, and high healthcare spending. Europe has the significant coverage of the market share due to the presence of opportunities for the growth. Asia Pacific is considered as the fastest growing market segment due to rapid developing technologies, increasing awareness among people and rising prevalence of Graves’ disease.

A full Report of Graves’ Disease Marketis Available at:  https://www.omrglobal.com/industry-reports/graves-disease-market

COMPANY PROFILES
ABBVIE INC.
ABBOTT LABORATORIES INC.
ALLERGAN PLC
APITOPE TECHNOLOGY LTD.
ASTRAZENECA PLC
BRISTOL-MYERS SQUIBB COMPANY
ELI LILLY AND COMPANY
EPIVAX, INC
GLAXOSMITHKLINE PLC
JOHNSON & JOHNSON
MACLEODS PHARMACEUTICALS LTD.
MERCK & CO., INC
MYLAN N.V
NOVARTIS INTERNATIONAL AG
OMEROS CORPORATION
PFIZER INC.
RLC LABS INC
RODOS BIOTARGET GMBH
SANOFI GENZYME
TAKEDA PHARMACEUTICAL COMPANY LIMITED

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/graves-disease-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no:  +91 7803040404

About Orion Market Research 
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.